The Shielded Patient List (SPL) identifies patients at the highest risk from coronavirus (COVID-19), based on criteria set by the Chief Medical Officer for England. We are responsible for weekly iterations of the SPL so support can be targeted to clinically extremely vulnerable people (CEV). The research to develop and validate the model is published in the British Medical Journal along with the underlying model for transparency.

Between September 2021 and June 2022 NHS Digital has been conducting a managed closure of the SPL. This Transparency Notice describes how your personal data will be processed upon closure of the SPL.deshielded proton here, because there are no electrons. Therefore this deshielded proton is going to experience the full effect of the applied magnetic fields. Alright, so, and we know We previously shared relevant information from the SPL with organisations who have responsibilities for providing care and support to the patients on the List. This included: If you have been shielding, we strongly urge you to take extra precautions following 1 April to keep yourself as safe as possible, such as continuing to observe social distancing and working from home. Data is disseminated via the Secure Electronic File Transfer service to the Government Digital Service, the National Commissioning Data Repository and other endpoints. It is also returned to the GP and prison health IT suppliers who use it to add codes to patient records to indicate they are on the list. New predictive risk model to help clinicians identify adults with multiple risk factors that make them more vulnerable to COVID-19

Between March 2020 and September 2021, the UK Chief Medical Officers (CMOs) identified and regularly reviewed the underlying clinical conditions for which people should be considered at high risk of complications from COVID-19 infection.NHS Digital previously updated the SPL when there were changes to patient status following a new diagnosis, or change in circumstance, or where a patient was identified as extremely vulnerable by their GP or hospital doctor or through the COVID-19 Population Risk Assessment.

NHS Digital developed a clinical methodology, a ruleset to identify patients who met these clinical conditions based on coded information in their health records. This methodology was updated as appropriate to reflect the guidance provided by the CMOs. We also used and shared information for planning, commissioning and research purposes, including clinical trials, relating to coronavirus. This included sharing information with NHS organisations, government departments, other public authorities and research organisations. With the prevalence of the virus in the community continuing to decrease now is the right time for people to start thinking about easing up on these more rigid guidelines. other people who have also been classed as clinically extremely vulnerable, based on clinical judgement and an assessment of their needs. GPs and hospital clinicians have been provided with guidance to support these decisionClinical commissioning groups (CCGs) received the list for the purpose of providing GP practices with support, and patients in their CCG area with support and care. Capita Severe depression and anxiety symptoms were twice as common among high risk older individuals who were socially isolating compared with average risk participants (32% vs 17%). Senior clinicians, including the Deputy Chief Medical Officer for England, Dr Jenny Harries, have recommended that shielding advice is paused nationally from 1 April onwards, as supported by the latest scientific evidence and advice. people who have had bone marrow or stem cell transplants in the last 6 months or who are still taking immunosuppression drugs